In a previous study of meta-analysis, T2DM risk showed to be strongly linked with elevated serum levels of inflammatory cytokines such as IL-1b, IL-6, IL-18, CRP, and TNF-α. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.